Payment overview · 2025
General Payments
$18.03
1 reported records · 1 companies
Healthcare provider profile · identity verified
Alan I Abramowitz, D.O.
Allopathic & Osteopathic Physicians|Internal Medicine · FOUNTAINVILLE, PA · NPI 1730181595
Verified facts
What the public records show
CMS Open Payments records show Alan I Abramowitz, D.O. received $18.03 in general payments during 2025 across 1 reported records.
Amgen Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
Amgen Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ENBREL as an associated drug or biological on 9330 records involving 2094 distinct recipient NPIs. Public Medicare Part D data also shows 24 claims for Enbrel by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $18.03 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $18.03 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $18.03 | 1 | 2025 |
Source payment records
|
|||||
| PROLIA Normalized: prolia |
Biological | Amgen Inc. | $18.03 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Amgen Inc. Exact reporting entity; no affiliate inference |
2025 | ENBREL open payments reported associated product |
CMS Open Payments — General Payments 9330 supporting records · 2094 recipient NPIs · example record 1226877474 |
Enbrel · 2024 Exact normalized brand match · 1 Part D row |
24 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1333 | 211 |
| Eliquis | Apixaban | 873 | 59 |
| Levothyroxine Sodium | Levothyroxine Sodium | 761 | 104 |
| Amlodipine Besylate | Amlodipine Besylate | 654 | 114 |
| Pantoprazole Sodium | Pantoprazole Sodium | 541 | 78 |
| Lisinopril | Lisinopril | 537 | 82 |
| Sertraline Hcl | Sertraline Hcl | 531 | 43 |
| Gabapentin | Gabapentin | 502 | 64 |
| Tamsulosin Hcl | Tamsulosin Hcl | 486 | 67 |
| Metformin Hcl | Metformin Hcl | 481 | 84 |
| Furosemide | Furosemide | 452 | 57 |
| Metoprolol Succinate | Metoprolol Succinate | 446 | 73 |
| Simvastatin | Simvastatin | 419 | 68 |
| Mirtazapine | Mirtazapine | 404 | 32 |
| Clopidogrel | Clopidogrel Bisulfate | 370 | 33 |
| Divalproex Sodium | Divalproex Sodium | 363 | 28 |
| Trazodone Hcl | Trazodone Hcl | 357 | 50 |
| Losartan Potassium | Losartan Potassium | 293 | 55 |
| Warfarin Sodium | Warfarin Sodium | 293 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 285 | 28 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 278 | 70 |
| Omeprazole | Omeprazole | 269 | 48 |
| Carvedilol | Carvedilol | 250 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 240 | 22 |
| Xarelto | Rivaroxaban | 224 | 12 |
| Hydrochlorothiazide | Hydrochlorothiazide | 223 | 57 |
| Potassium Chloride | Potassium Chloride | 215 | 29 |
| Pravastatin Sodium | Pravastatin Sodium | 213 | 17 |
| Haloperidol | Haloperidol | 203 | suppressed |
| Famotidine | Famotidine | 202 | 23 |
| Fluoxetine Hcl | Fluoxetine Hcl | 202 | 34 |
| Escitalopram Oxalate | Escitalopram Oxalate | 196 | 32 |
| Levetiracetam | Levetiracetam | 194 | 24 |
| Farxiga | Dapagliflozin Propanediol | 189 | 13 |
| Januvia | Sitagliptin Phosphate | 178 | 13 |
| Buspirone Hcl | Buspirone Hcl | 176 | 19 |
| Finasteride | Finasteride | 172 | 33 |
| Metoprolol Tartrate | Metoprolol Tartrate | 172 | 31 |
| Midodrine Hcl | Midodrine Hcl | 170 | 22 |
| Risperidone | Risperidone | 169 | 15 |
| Bupropion Xl | Bupropion Hcl | 168 | suppressed |
| Lorazepam | Lorazepam | 162 | 45 |
| Olanzapine | Olanzapine | 154 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 152 | 40 |
| Allopurinol | Allopurinol | 150 | 29 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 141 | 13 |
| Baclofen | Baclofen | 138 | 16 |
| Prednisone | Prednisone | 129 | 63 |
| Citalopram Hbr | Citalopram Hydrobromide | 127 | 20 |
| Donepezil Hcl | Donepezil Hcl | 121 | 15 |
| Entresto | Sacubitril/Valsartan | 118 | suppressed |
| Jardiance | Empagliflozin | 115 | suppressed |
| Ramipril | Ramipril | 110 | 31 |
| Hydralazine Hcl | Hydralazine Hcl | 104 | 16 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 104 | 22 |
| Lithium Carbonate | Lithium Carbonate | 104 | suppressed |
| Xifaxan | Rifaximin | 97 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 96 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 92 | 13 |
| Ezetimibe | Ezetimibe | 91 | 15 |
| Lamotrigine | Lamotrigine | 91 | suppressed |
| Spironolactone | Spironolactone | 91 | 18 |
| Ozempic | Semaglutide | 88 | 16 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 86 | 11 |
| Propranolol Hcl | Propranolol Hcl | 86 | suppressed |
| Novolog Flexpen | Insulin Aspart | 85 | 24 |
| Memantine Hcl | Memantine Hcl | 84 | 16 |
| Montelukast Sodium | Montelukast Sodium | 84 | 16 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 77 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 77 | suppressed |
| Aripiprazole | Aripiprazole | 76 | 13 |
| Atenolol | Atenolol | 76 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 76 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 72 | suppressed |
| Glimepiride | Glimepiride | 72 | 16 |
| Lovastatin | Lovastatin | 72 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 70 | 24 |
| Venlafaxine Hcl | Venlafaxine Hcl | 70 | suppressed |
| Fenofibrate | Fenofibrate | 68 | suppressed |
| Lactulose | Lactulose | 65 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 65 | suppressed |
| Latanoprost | Latanoprost | 64 | 15 |
| Zolpidem Tartrate | Zolpidem Tartrate | 64 | 18 |
| Fluticasone Propionate | Fluticasone Propionate | 63 | 24 |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 61 | 60 |
| Dapagliflozin | Dapagliflozin Propanediol | 58 | suppressed |
| Meloxicam | Meloxicam | 58 | 13 |
| Topiramate | Topiramate | 56 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 55 | suppressed |
| Myrbetriq | Mirabegron | 55 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 54 | suppressed |
| Calcitriol | Calcitriol | 53 | suppressed |
| Tradjenta | Linagliptin | 53 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 53 | suppressed |
| Carbamazepine | Carbamazepine | 52 | suppressed |
| Clonazepam | Clonazepam | 52 | 19 |
| Alprazolam | Alprazolam | 51 | 22 |
| Valsartan | Valsartan | 50 | suppressed |
| Lubiprostone | Lubiprostone | 48 | suppressed |
| Torsemide | Torsemide | 48 | suppressed |
| Vascepa | Icosapent Ethyl | 48 | suppressed |
| Amantadine | Amantadine Hcl | 47 | suppressed |
| Calcium Acetate | Calcium Acetate | 46 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 46 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 46 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 45 | suppressed |
| Glipizide | Glipizide | 45 | suppressed |
| Nifedipine Er | Nifedipine | 45 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 44 | 29 |
| Amitriptyline Hcl | Amitriptyline Hcl | 44 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 44 | suppressed |
| Clozapine | Clozapine | 44 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 41 | 34 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 41 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 40 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 40 | suppressed |
| Cephalexin | Cephalexin | 39 | 21 |
| Metformin Er Osmotic | Metformin Hcl | 39 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 38 | suppressed |
| Synthroid | Levothyroxine Sodium | 38 | 11 |
| Tizanidine Hcl | Tizanidine Hcl | 38 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 36 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 36 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 36 | 11 |
| Budesonide | Budesonide | 35 | suppressed |
| Celecoxib | Celecoxib | 35 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 35 | suppressed |
| Azithromycin | Azithromycin | 34 | 28 |
| Glucagon Emergency Kit | Glucagon | 34 | 12 |
| Sucralfate | Sucralfate | 34 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 33 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 33 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 31 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 30 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 29 | 11 |
| Ranolazine Er | Ranolazine | 29 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 28 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 28 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 28 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 28 | 17 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 28 | 15 |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 27 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 26 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 26 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 26 | suppressed |
| Irbesartan | Irbesartan | 25 | suppressed |
| Methocarbamol | Methocarbamol | 25 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 25 | suppressed |
| Alogliptin | Alogliptin Benzoate | 24 | suppressed |
| Enbrel | Etanercept | 24 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 24 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 24 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 23 | 17 |
| Incruse Ellipta | Umeclidinium Bromide | 23 | suppressed |
| Ketoconazole | Ketoconazole | 23 | suppressed |
| Perphenazine | Perphenazine | 23 | suppressed |
| Risperidone Er | Risperidone Microspheres | 23 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 22 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 22 | 14 |
| Repaglinide | Repaglinide | 22 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 21 | 21 |
| Hydrocortisone | Hydrocortisone | 21 | suppressed |
| Methylprednisolone | Methylprednisolone | 21 | suppressed |
| Temazepam | Temazepam | 21 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 20 | suppressed |
| Colchicine | Colchicine | 20 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 20 | suppressed |
| Bumetanide | Bumetanide | 19 | suppressed |
| Methotrexate | Methotrexate Sodium | 19 | suppressed |
| Actemra | Tocilizumab | 18 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 18 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 18 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 17 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 17 | suppressed |
| Lansoprazole | Lansoprazole | 17 | suppressed |
| Levalbuterol Hcl | Levalbuterol Hcl | 17 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 17 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 17 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 17 | suppressed |
| Admelog Solostar | Insulin Lispro | 16 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 16 | suppressed |
| Amoxicillin | Amoxicillin | 16 | 12 |
| Azelastine Hcl | Azelastine Hcl | 16 | suppressed |
| Ibuprofen | Ibuprofen | 16 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 16 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 16 | suppressed |
| Pregabalin | Pregabalin | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Tetrabenazine | Tetrabenazine | 16 | suppressed |
| Ursodiol | Ursodiol | 16 | suppressed |
| Gemtesa | Vibegron | 15 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 15 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 15 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 15 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 15 | suppressed |
| Travoprost | Travoprost | 15 | suppressed |
| Verapamil Er | Verapamil Hcl | 15 | suppressed |
| Gemfibrozil | Gemfibrozil | 14 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 14 | suppressed |
| Lithium Carbonate Er | Lithium Carbonate | 14 | suppressed |
| Mounjaro | Tirzepatide | 14 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 14 | suppressed |
| Acetazolamide | Acetazolamide | 13 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 13 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Metolazone | Metolazone | 13 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | suppressed |
| Nadolol | Nadolol | 13 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 12 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 12 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 12 | 12 |
| Descovy | Emtricitabine/Tenofov Alafenam | 12 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 12 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 12 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Leflunomide | Leflunomide | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Paliperidone Er | Paliperidone | 12 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 12 | suppressed |
| Prezcobix | Darunavir/Cobicistat | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Tyrvaya | Varenicline Tartrate | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 11 | suppressed |
| Letrozole | Letrozole | 11 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 11 | suppressed |
| Trulicity | Dulaglutide | 11 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $18.03 · 1 records | Amgen Inc. | EVENITY, PROLIA | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Amgen Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error